| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,603 | 28,729 | 30,053 | 31,952 | | Cost of Revenue | 9,358 | 11,220 | 12,841 | 13,668 | | | Gross Profit |
-
| 17,509 | 17,212 | 18,284 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,450 | 11,898 | 10,305 | 10,507 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 10,867 | 11,966 | 10,867 | 4,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (6,355) | (3,960) | 3,777 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (6,072) | (6,355) | (3,960) | 3,777 | | Interest Expense | 2,968 | 3,196 | 3,375 | 3,961 | | Income Before Tax | (9,040) | (9,551) | (7,335) | (184) | | Income Tax Expense | (3,754) | (3,326) | (2,846) | (496) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,286) | (6,225) | (4,489) | 312 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,286) | (6,225) | (4,489) | 312 | | Preferred Stock And Other Adjustments | (320) | (163) |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,606) | ($6,388) | ($4,489) | $312 |
|
0.26% Nasdaq 
Income Statement
